“Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents with Moderate-to-Severe AD and Skin of Color” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s625. doi:10.25251/0262jz84.